299 related articles for article (PubMed ID: 9342064)
1. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region.
Chang HC; Samaniego F; Nair BC; Buonaguro L; Ensoli B
AIDS; 1997 Oct; 11(12):1421-31. PubMed ID: 9342064
[TBL] [Abstract][Full Text] [Related]
2. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor.
Barillari G; Sgadari C; Fiorelli V; Samaniego F; Colombini S; Manzari V; Modesti A; Nair BC; Cafaro A; Stürzl M; Ensoli B
Blood; 1999 Jul; 94(2):663-72. PubMed ID: 10397733
[TBL] [Abstract][Full Text] [Related]
3. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.
Klagsbrun M
Semin Cancer Biol; 1992 Apr; 3(2):81-7. PubMed ID: 1378313
[TBL] [Abstract][Full Text] [Related]
4. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor.
Brown KJ; Parish CR
Biochemistry; 1994 Nov; 33(46):13918-27. PubMed ID: 7524669
[TBL] [Abstract][Full Text] [Related]
5. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
Brown KJ; Hendry IA; Parish CR
J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
[TBL] [Abstract][Full Text] [Related]
6. Evidence that both receptor- and heparan sulfate proteoglycan-bound basic fibroblast growth factor are internalized by cultured immature Leydig cells.
Murono EP; Washburn AL; Goforth DP; Wu N
Mol Cell Endocrinol; 1993 Dec; 98(1):81-90. PubMed ID: 8143917
[TBL] [Abstract][Full Text] [Related]
7. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix.
Benezra M; Vlodavsky I; Ishai-Michaeli R; Neufeld G; Bar-Shavit R
Blood; 1993 Jun; 81(12):3324-31. PubMed ID: 8507869
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan.
Brunner G; Gabrilove J; Rifkin DB; Wilson EL
J Cell Biol; 1991 Sep; 114(6):1275-83. PubMed ID: 1654337
[TBL] [Abstract][Full Text] [Related]
9. Elastase-mediated release of heparan sulfate proteoglycans from pulmonary fibroblast cultures. A mechanism for basic fibroblast growth factor (bFGF) release and attenuation of bfgf binding following elastase-induced injury.
Buczek-Thomas JA; Nugent MA
J Biol Chem; 1999 Aug; 274(35):25167-72. PubMed ID: 10455199
[TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form.
Presta M; Maier JA; Rusnati M; Ragnotti G
J Cell Physiol; 1989 Jul; 140(1):68-74. PubMed ID: 2500452
[TBL] [Abstract][Full Text] [Related]
11. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
Forsten-Williams K; Chua CC; Nugent MA
J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
[TBL] [Abstract][Full Text] [Related]
12. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.
Saksela O; Rifkin DB
J Cell Biol; 1990 Mar; 110(3):767-75. PubMed ID: 2137829
[TBL] [Abstract][Full Text] [Related]
13. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
14. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size.
Rusnati M; Coltrini D; Oreste P; Zoppetti G; Albini A; Noonan D; d'Adda di Fagagna F; Giacca M; Presta M
J Biol Chem; 1997 Apr; 272(17):11313-20. PubMed ID: 9111037
[TBL] [Abstract][Full Text] [Related]
15. Sulfate moieties in the subendothelial extracellular matrix are involved in basic fibroblast growth factor sequestration, dimerization, and stimulation of cell proliferation.
Miao HQ; Ishai-Michaeli R; Atzmon R; Peretz T; Vlodavsky I
J Biol Chem; 1996 Mar; 271(9):4879-86. PubMed ID: 8617759
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules.
Bashkin P; Doctrow S; Klagsbrun M; Svahn CM; Folkman J; Vlodavsky I
Biochemistry; 1989 Feb; 28(4):1737-43. PubMed ID: 2541764
[TBL] [Abstract][Full Text] [Related]
17. Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.
Bugatti A; Urbinati C; Ravelli C; De Clercq E; Liekens S; Rusnati M
Antimicrob Agents Chemother; 2007 Jul; 51(7):2337-45. PubMed ID: 17452490
[TBL] [Abstract][Full Text] [Related]
18. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans.
Tyagi M; Rusnati M; Presta M; Giacca M
J Biol Chem; 2001 Feb; 276(5):3254-61. PubMed ID: 11024024
[TBL] [Abstract][Full Text] [Related]
19. Internalization of basic fibroblast growth factor at the mouse blood-brain barrier involves perlecan, a heparan sulfate proteoglycan.
Deguchi Y; Okutsu H; Okura T; Yamada S; Kimura R; Yuge T; Furukawa A; Morimoto K; Tachikawa M; Ohtsuki S; Hosoya K; Terasaki T
J Neurochem; 2002 Oct; 83(2):381-9. PubMed ID: 12423248
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity.
Nugent MA; Edelman ER
Biochemistry; 1992 Sep; 31(37):8876-83. PubMed ID: 1390674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
